| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | |
|---|---|---|---|---|---|---|
Cash flows from operating activities | ||||||
Net loss | ||||||
-27,048 | -24,162 | -11,605 | -6,213 | -8,741 | -11,057 | |
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||
Share-based compensation | ||||||
2,871 | 3,805 | 6,018 | 966 | 356 | 0 | |
Write-off of deferred offering costs | ||||||
100 | 0 | - | - | - | - | |
Accrued interest on convertible notes | ||||||
0 | 280 | - | - | - | - | |
Accrued interest on convertible notes | ||||||
- | - | 396 | - | - | - | |
Amortization of debt discount | ||||||
1,067 | 2,513 | 39 | - | - | - | |
Depreciation | ||||||
21 | 19 | 5 | - | - | - | |
Beneficial conversion feature | ||||||
0 | 3,077 | 0 | - | - | - | |
Change in fair value of derivative liability | ||||||
-873 | -50 | 0 | - | - | - | |
Change in fair value of warrant liability | ||||||
54 | 0 | - | - | - | - | |
Warrant inducement expense | ||||||
1,265 | 0 | - | - | - | - | |
Extinguishment of derivative liability | ||||||
370 | 0 | - | - | - | - | |
Amortization of deferred debt issuance costs and debt discount | ||||||
- | - | - | 740 | 583 | 1,147 | |
Amortization of trademark | ||||||
- | - | - | 131 | 54 | 0 | |
Trademark impairment | ||||||
- | - | - | 0 | - | - | |
Gain on settlement of customer refund | ||||||
- | - | - | 0 | - | - | |
Loss on extinguishment of debt | ||||||
-1,049 | 0 | - | 0 | - | - | |
Gain on debt conversion | ||||||
- | - | - | 557 | 0 | - | |
Accrued interest on debt converted to equity | ||||||
- | - | - | - | - | 98 | |
Provision for doubtful accounts | ||||||
- | - | - | 153 | 179 | 401 | |
Debt conversion expense | ||||||
- | - | - | - | 898 | 2,707 | |
Changes in operating assets and liabilities: | ||||||
Prepaid expenses and other assets | ||||||
50 | 298 | 155 | - | - | - | |
Accounts receivable | ||||||
- | - | - | 365 | -2,746 | 3,100 | |
Inventories | ||||||
- | - | - | 472 | -1,954 | 1,843 | |
Prepaid expenses and other | ||||||
- | - | - | 478 | 73 | -82 | |
Other assets | ||||||
- | - | - | - | -28 | 17 | |
Accounts payable | ||||||
124 | 86 | 746 | -753 | -585 | 2,928 | |
Accrued expenses | ||||||
3,921 | -441 | -543 | -1,569 | -887 | 1,321 | |
Accrued interest | ||||||
-101 | 0 | - | - | - | - | |
Customer refund | ||||||
- | - | - | -10 | 1,850 | 0 | |
Due to related party | ||||||
- | - | - | 0 | -92 | -119 | |
Net cash used in operating activities | ||||||
-17,967 | -15,169 | -5,096 | -8,427 | - | - | |
Cash flows from investing activities | ||||||
Purchase of property and equipment | ||||||
11 | 13 | 38 | - | - | - | |
Purchase of restricted deposit | ||||||
0 | 75 | 0 | - | - | - | |
Loan payments from related party | ||||||
0 | 75 | 0 | - | - | - | |
Net cash provided by investing activities | ||||||
-11 | -13 | -38 | - | - | - | |
Cash flows from financing activities | ||||||
Borrowings from convertible notes | ||||||
5,000 | 3,345 | 0 | - | - | - | |
Private placement offering | ||||||
- | - | - | - | 2,969 | 0 | |
Proceeds from short-term loan - related party | ||||||
- | - | - | 0 | 100 | 460 | |
Payments on short-term loan - related party | ||||||
- | - | - | - | 151 | 0 | |
Proceeds from issuance of convertible debt and warrants | ||||||
- | - | - | - | 1,645 | 3,466 | |
Proceeds from issuance of bridge financing | ||||||
- | - | - | 406 | 2,955 | 0 | |
Payments on bridge financing | ||||||
- | - | - | 462 | - | - | |
Proceeds from credit facility | ||||||
- | - | - | 641 | 6,902 | 14,599 | |
Payments on credit facility | ||||||
- | - | - | 845 | 11,738 | 10,337 | |
Payments on trademark note payable | ||||||
- | - | - | 450 | 50 | 0 | |
Payments of debt issuance costs | ||||||
57 | 50 | 0 | 57 | 880 | 640 | |
Borrowings from convertible promissory notes | ||||||
- | - | 5,130 | - | - | - | |
Payments of convertible notes | ||||||
7,790 | 275 | 0 | - | - | - | |
Net cash used in operating activities | ||||||
- | - | - | - | -1,730 | -7,452 | |
Proceeds from issuance of preferred stock, net | ||||||
- | - | - | 2,393 | 0 | - | |
Proceeds from issuance of common stock and warrants | ||||||
20,706 | 18,132 | 0 | 673 | 0 | - | |
Payment of deferred offering costs | ||||||
- | - | 0 | - | - | - | |
Proceeds from exercise of stock options | ||||||
30 | 182 | 0 | - | - | - | |
Proceeds from exercise of warrants | ||||||
0 | 928 | 0 | - | - | - | |
Issuance of common stock in connection with warrants exercise | ||||||
- | - | - | 0 | - | - | |
Proceeds from the issuance of convertible notes | ||||||
- | - | - | 0 | - | - | |
Debt discount | ||||||
- | - | - | 0 | 0 | - | |
Proceeds from issuance of IPO common stock and warrants | ||||||
- | - | - | 8,151 | 0 | - | |
Payment of deferred offering costs | ||||||
1,045 | 1,706 | 0 | 689 | 0 | - | |
Payment of stock subscription receivable | ||||||
- | - | 0 | - | - | - | |
Net cash provided by financing activities | ||||||
16,843 | 20,556 | 5,130 | 9,761 | - | - | |
Net (decrease) increase in cash and cash equivalents | ||||||
-1,135 | 5,373 | - | - | - | - | |
Net increase in cash and cash equivalents | ||||||
- | - | -5 | - | - | - | |
Net cash provided by financing activities | ||||||
- | - | - | - | 1,752 | 7,548 | |
Net increase (decrease) in cash | ||||||
- | - | - | 1,334 | 22 | 96 | |
Supplemental disclosure of cash flow information | ||||||
Cash paid during the period for interest | ||||||
874 | 280 | 0 | 59 | 333 | 370 | |
Income taxes | ||||||
- | - | - | 2 | 2 | 13 | |
Supplemental disclosure of non-cash financing activities | ||||||
Conversion of related party debt into equity | ||||||
- | - | - | 0 | - | - | |
Conversion of related party debt into equity | ||||||
- | - | - | - | 2,272 | 5,870 | |
Warrants issued in connection with notes payable | ||||||
- | - | - | 0 | - | - | |
Conversion of convertible notes and accrued interest to common stock | ||||||
0 | 9,229 | 0 | - | 2,103 | 0 | |
Assumption of liabilities from reverse recapitalization transaction | ||||||
0 | 978 | 0 | - | - | - | |
Warrants issued to placement agents | ||||||
0 | 913 | 0 | - | - | - | |
Commissions payable in connection with exercise of warrants | ||||||
0 | 87 | - | - | - | - | |
Commissions owed and accrued for exercise of warrants | ||||||
- | - | 0 | - | - | - | |
Accrued interest converted to convertible note payable | ||||||
0 | 156 | 0 | - | - | - | |
Non-cash addition of derivative liability | ||||||
1,281 | 420 | - | - | - | - | |
Non-cash addition of deferred offering costs | ||||||
151 | 54 | - | - | - | - | |
Non-cash addition of derivative liability | ||||||
1,281 | 420 | 0 | - | - | - | |
Non-cash addition of deferred offering costs | ||||||
151 | 54 | 159 | - | - | - | |
Deferred offering costs reclassified to additional paid-in capital | ||||||
0 | 159 | 0 | - | - | - | |
Exchange of debt for equity | ||||||
- | - | - | 0 | 592 | 45 | |
Reclassification of deferred IPO costs | ||||||
- | - | - | 619 | 0 | - | |